Rocuronium bromide and Pupillary reflex impaired - a phase IV clinical study of FDA data

Summary:

Pupillary reflex impaired is reported as a side effect among people who take Rocuronium bromide (rocuronium bromide), especially for people who are female, 40-49 old, also take Simvastatin, and have Depression.

The phase IV clinical study analyzes which people have Pupillary reflex impaired when taking Rocuronium bromide. It is created by eHealthMe based on reports of 5,609 people who have side effects when taking Rocuronium bromide from the FDA, and is updated regularly.

What is Rocuronium bromide?

Rocuronium bromide has active ingredients of rocuronium bromide. eHealthMe is studying from 5,615 Rocuronium bromide users. Check the latest studies of Rocuronium bromide.

What is Pupillary reflex impaired?

Pupillary reflex impaired is found to be associated with 293 drugs and 549 conditions by eHealthMe. Check the latest studies of Pupillary reflex impaired.

On Jul, 08, 2026

5,609 people reported to have side effects when taking Rocuronium bromide.
Among them, 31 people (0.55%) have Pupillary reflex impaired.

Could Rocuronium bromide cause Pupillary reflex impaired?

Among these 31 people:

What is the gender of people who have Pupillary reflex impaired when taking Rocuronium bromide? *

female: 100 %
male: 0.0 %

What is the age of people who have Pupillary reflex impaired when taking Rocuronium bromide? *

What are other drugs people take besides Rocuronium bromide? *

Felodipine: 26 people, 83.87%
Propofol: 26 people, 83.87%
Morphine: 26 people, 83.87%
Atenolol: 26 people, 83.87%
Simvastatin: 26 people, 83.87%
Isosorbide Mononitrate: 25 people, 80.65%
Citalopram Hydrobromide: 21 people, 67.74%
Aspirin: 20 people, 64.52%
Dexamethasone: 18 people, 58.06%
Alfentanil: 8 people, 25.81%

What are other side effects people have besides Pupillary reflex impaired? *

Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 25 people, 80.65%
Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 21 people, 67.74%
Agitation (state of anxiety or nervous excitement): 20 people, 64.52%
Staring (a prolonged gaze or fixed look): 18 people, 58.06%
Mydriasis (a dilation of the pupil): 18 people, 58.06%
Glasgow Coma Scale Abnormal: 16 people, 51.61%
Blood Phosphorus Increased: 15 people, 48.39%
Drug Toxicity: 15 people, 48.39%
Speech Disorder: 14 people, 45.16%
Akathisia (a movement disorder characterized by a feeling of inner restlessness): 13 people, 41.94%

What are the existing conditions these people have? *

Depression: 17 people, 54.84%
Sedation: 15 people, 48.39%
Analgesia: 15 people, 48.39%
Anaesthesia: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Rocuronium bromide and have Pupillary reflex impaired?

- Check whether Pupillary reflex impaired is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rocuronium bromide:

Rocuronium bromide (5,615 reports)

Browse all side effects of Rocuronium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pupillary reflex impaired:

Pupillary reflex impaired (293 drugs)

Browse all the conditions that are associated with Pupillary reflex impaired:

Pupillary reflex impaired (549 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide (the active ingredients of Rocuronium bromide) and Rocuronium bromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.